Northbrooke Research Center

Brown Deer, Wisconsin 53223

0 studies enrolling now · 12 studies all time

What they study most

Depression, Major Depressive Disorder, Obsessive-Compulsive Disorder

Studies at this site

• A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression — Stopped early
• Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD) — Completed
• Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder — Completed
• Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder — Completed
• Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder — Completed
• Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression — Stopped early
• Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression — Completed
• A Study of Aripiprazole in Patients With Major Depressive Disorder — Completed
• Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder — Stopped early
• A Study of CX157 (TriRima) for the Treatment of Depression — Completed
• Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder — Completed
• Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder — Completed